Despite progressive innovations to end the HIV epidemic, barriers exist to HIV prevention services such as pre-exposure prophylaxis (PrEP) care, particularly for underserved populations. To expand the reach of PrEP while addressing existing disparities and inequities in the HIV care continuum, community practitioners need to be educated on evidence-based PrEP medications and PrEP guidelines as well as bias, cultural sensitivity, and structural barriers.
In this CME Outfitters Snack, a diverse panel of expert faculty will discuss PrEP options, PrEP guidelines, implicit bias in underserved communities, tools for measuring bias, clinical approaches to PrEP conversations, and strategies for individualizing PrEP care to facilitate equitable access in clinical practice and public health.
This program has been supported by an independent educational grant from Gilead Sciences, Inc.
Primary care physicians, physician associates (PAs), nurse practitioners (NPs), nurses, and pharmacists.
It is the policy of CME Outfitters, LLC, to ensure independence, balance, objectivity, and scientific rigor and integrity in all of their CE activities. Faculty must disclose to the participants any relationships with commercial companies whose products or devices may be mentioned in faculty presentations, or with the commercial supporter of this CE activity. CME Outfitters, LLC, has evaluated, identified, and mitigated any potential conflicts of interest through a rigorous content validation procedure, use of evidence-based data/research, and a multidisciplinary peer review process.
Dr. Blackstock reports the following financial relationships: Advisory Board: Health Equity Advisory Board member for ViiV Healthcare
Dr. Guilamo-Ramos reports the following financial relationships: Advisory Board: Positive Action for Youth (PAFY) Advisory Board Member, ViiV Healthcare
Disclosures were obtained from the CME Outfitters, LLC staff; no disclosures to report:
Faculty of this CE activity may include discussions of products or devices that are not currently labeled for use by the FDA. The faculty have been informed of their responsibility to disclose to the audience if they will be discussing off-label or investigational uses (any uses not approved by the FDA) of products or devices.
Call us at 877.CME.PROS (877.263.7767).